Corcept Therapeutics | CORT - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Acadia Pharmaceuticals USD 146.88M 1.69M 2026-09
Alaunos Therapeutics USD 424K 23K 2026-06
ANI Pharmaceuticals USD 94.86M 3.2M 2026-09
Ardelyx USD 101.44M 827K 2026-06
Aurora Cannabis CAD 40.89M 515K 2026-06
BioMarin Pharmaceutical USD 333.64M 61.91M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Canopy Growth CAD 33.99M 2.83M 2026-06
Corcept Therapeutics USD 142.04M 14.86M 2026-09
Eli Lilly USD 3.12B 305M 2026-09
J&J USD 6.25B 168M 2026-09
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Merck USD 2.86B 25M 2026-09
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Novartis USD 3.08B 163M 2026-09
Novartis USD 3.08B 58M 2026-09
Omeros USD 11.32M 2.48M 2024-09
Pacira USD 950.8M 858.99M 2026-09
Pfizer USD 3.28B 132M 2026-09
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
TG Therapeutics USD 62.32M 10.82M 2026-06